CCM
AGIO icon

Cloud Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Cloud Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed – – 143
2025
Q3 		$0 Buy
+1
New +$38 ﹤0.01% 992

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Cloud Capital Management's AGIO Position: Q4 2025 in Review

Cloud Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 1 share.

Cloud Capital Management first reported a position in AGIO in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 237 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Cloud Capital Management reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Cloud Capital Management sold 1 Agios Pharmaceuticals share in Q4 2025.
  • Cloud Capital Management first reported a position in Agios Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Cloud Capital Management's Agios Pharmaceuticals position peaked at $0 in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.